During the past decade, Kansas City Cancer Centers - South conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City Cancer Centers - South" #1 sponsor was "Radiation Therapy Oncology Group" with 8 trials, followed by "SWOG Cancer Research Network" with 5 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "CTI BioPharma" with 1 trials sponsored and "Heron Therapeutics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City Cancer Centers - South" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City Cancer Centers - South" are "Prostate Cancer" (5 trials), "Lung Cancer" (3 trials), "Brain and Central Nervous System Tumors" (2 trials), "Colorectal Cancer" (2 trials) and "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials). Many other conditions were trialed in "Kansas City Cancer Centers - South" in a lesser frequency.

Most popular intervention types in "Kansas City Cancer Centers - South" are "Drug" (14 trials), "Radiation" (10 trials), "Other" (5 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "LHRH agonist" (2 trials), "Prednisone" (2 trials), "capecitabine" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City Cancer Centers - South" are 12 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kansas City Cancer Centers - South". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Kansas City Cancer Centers - South, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City Cancer Centers - South, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".